Orris

TITLE: A STUDY OF RED CELL DISTRIBUTION WIDTH AS A PROGNOSTIC MARKER IN PATIENTS WITH HEART FAILURE what would be statistical test used for this study

Reading File
Finding Sources
Searching PubMed

"heart failure" AND "red cell distribution width"

Searching the Web

red cell distribution width heart failure prognostic marker Cox regression survival analysis

For a study titled “Red Cell Distribution Width as a Prognostic Marker in Patients with Heart Failure”, the primary statistical test depends on how you define the prognosis outcome.

If prognosis is time to death or hospital readmission

Use survival analysis:
  • Kaplan-Meier survival curves to compare event-free survival between RDW groups, such as normal versus elevated RDW or RDW quartiles.
  • Log-rank test to test whether the survival curves differ.
  • Cox proportional-hazards regression as the main multivariable test to determine whether RDW independently predicts mortality or heart-failure hospitalization. Report adjusted hazard ratios (HRs), 95% confidence intervals, and p-values.
Adjust the Cox model for potential confounders such as age, sex, hemoglobin/anemia, renal function, LVEF, NYHA class, diabetes, BNP/NT-proBNP, and relevant medications. This approach is commonly used in prognostic RDW-heart-failure studies, including a recent cohort report using Cox regression, and earlier major prognostic studies. Example cohort study

If prognosis is a binary outcome

For example, death within 6 months: yes/no, use:
  • Binary logistic regression
  • Report adjusted odds ratios (ORs) with 95% CIs.

Supporting analyses

  • Independent t-test or Mann-Whitney U test: compare continuous RDW between outcome groups.
  • Chi-square test or Fisher’s exact test: compare proportions, for example mortality in high versus low RDW groups.
  • ROC curve analysis: assess how well RDW predicts mortality/readmission and identify a possible cut-off. Report AUC, sensitivity, specificity, and 95% CI.
  • Correlation: Pearson or Spearman correlation if relating RDW to continuous measures such as LVEF, NT-proBNP, or duration of hospital stay.
  • Multivariable linear regression: only if the outcome is continuous, such as length of stay.
Best concise answer for your protocol:
Kaplan-Meier analysis with log-rank test and multivariable Cox proportional-hazards regression will be used to evaluate RDW as an independent prognostic marker for mortality and/or heart-failure hospitalization.
RDW may be entered as a continuous variable (often most statistically efficient, e.g., HR per 1% increase in RDW) and, secondarily, as categories or quartiles for clinical interpretation. Ensure the Cox proportional-hazards assumption is checked.

How do I calculate the required sample size?

Reading File
Finding Sources
Searching PubMed

"heart failure" AND "red cell distribution width"

Searching the Web

sample size Cox proportional hazards regression Schoenfeld number events formula

For your study, if the primary outcome is time to death or time to heart-failure readmission, calculate sample size based on the number of outcome events, because the main analysis is Cox proportional-hazards regression.

1. Specify these assumptions first

  1. Primary outcome: all-cause mortality, cardiovascular mortality, or a composite of death/readmission
  2. Follow-up duration: for example, 6 months or 1 year
  3. Expected event rate during follow-up, based on hospital data or published studies
  4. Effect size: the hazard ratio (HR) you wish to detect for high versus low RDW
  5. Significance level: usually two-sided α = 0.05
  6. Power: usually 80% or 90%
  7. Proportion with high RDW: if using a high/low RDW classification
  8. Expected losses to follow-up: commonly 5% to 10%

2. Calculate the required number of events

For RDW categorized as high versus normal/low, use the Schoenfeld formula:
[ D = \frac{(Z_{1-\alpha/2}+Z_{1-\beta})^2} {q(1-q)[\ln(HR)]^2} ]
Where:
  • (D) = required number of events, such as deaths or the composite endpoint
  • (Z_{1-\alpha/2}) = 1.96 for two-sided α = 0.05
  • (Z_{1-\beta}) = 0.84 for 80% power, or 1.28 for 90% power
  • (q) = expected proportion in the high-RDW group
  • (HR) = target hazard ratio for high RDW versus low RDW
This is the standard basis for Cox-regression/log-rank survival-study sample-size planning. Schoenfeld formula overview

3. Convert required events to participants

[ N = \frac{D}{\text{expected event proportion}} ]
Then adjust for loss to follow-up:
[ N_{\text{final}} = \frac{N}{1-\text{anticipated dropout proportion}} ]

Worked example

Assume:
  • Primary outcome: 1-year all-cause mortality
  • Expected HR for high RDW: 1.50
  • High RDW group proportion: 50%
  • α = 0.05, two-sided
  • Power = 80%
  • Expected 1-year event rate: 25%
  • Loss to follow-up: 10%

Required events

[ D = \frac{(1.96+0.84)^2}{0.5(1-0.5)[\ln(1.5)]^2} ]
[ D = \frac{7.84}{0.25 \times 0.1644} = 190.8 ]
So, you need approximately 191 events.

Required participants

[ N = \frac{191}{0.25}=764 ]
Adjustment for 10% loss to follow-up:
[ N_{\text{final}} = \frac{764}{0.90}=849 ]
Required sample size: approximately 850 patients.

Important practical point

If you plan an adjusted Cox model with, for example, RDW plus age, sex, LVEF, NYHA class, hemoglobin, creatinine/eGFR, diabetes, NT-proBNP, and treatment variables, also ensure enough events for the number of parameters. A practical target is at least 10 to 20 events per regression parameter.
For example:
  • 8 variables/parameters in the final model
  • Minimum event target: 80 to 160 events
  • The example calculation requires 191 events, so it is adequate for this model.

Protocol wording

Sample size will be calculated for Cox proportional-hazards regression using the Schoenfeld method. Assuming a two-sided alpha of 0.05, 80% power, hazard ratio of 1.50 for elevated versus normal RDW, equal distribution of participants between RDW groups, an anticipated event rate of 25% during follow-up, and 10% loss to follow-up, approximately 850 participants will be required.
If you provide your expected event rate, intended follow-up period, desired power, and HR from a reference study or pilot data, I can calculate the exact sample size for your protocol.

Calculate my exact sample size using my study assumptions

Reading File
To calculate an exact defensible sample size, I need the assumptions you intend to use.
Asking for Preferences

What is your primary prognostic outcome? · Please provide the assumptions to calculate it: target hazard ratio (high vs low RDW), expected event rate during follow-up, planned follow-up period, power (80%/90%), and expected loss to follow-up. If you do not have them, select this option.

For a study titled “Red Cell Distribution Width as a Prognostic Marker in Patients with Heart Failure”, the primary statistical test depends on how you define the prognosis outcome.

If prognosis is time to death or hospital readmission

Use survival analysis:
  • Kaplan-Meier survival curves to compare event-free survival between RDW groups, such as normal versus elevated RDW or RDW quartiles.
  • Log-rank test to test whether the survival curves differ.
  • Cox proportional-hazards regression as the main multivariable test to determine whether RDW independently predicts mortality or heart-failure hospitalization. Report adjusted hazard ratios (HRs), 95% confidence intervals, and p-values.
Adjust the Cox model for potential confounders such as age, sex, hemoglobin/anemia, renal function, LVEF, NYHA class, diabetes, BNP/NT-proBNP, and relevant medications. This approach is commonly used in prognostic RDW-heart-failure studies, including a recent cohort report using Cox regression, and earlier major prognostic studies. Example cohort study

If prognosis is a binary outcome

For example, death within 6 months: yes/no, use:
  • Binary logistic regression
  • Report adjusted odds ratios (ORs) with 95% CIs.

Supporting analyses

  • Independent t-test or Mann-Whitney U test: compare continuous RDW between outcome groups.
  • Chi-square test or Fisher’s exact test: compare proportions, for example mortality in high versus low RDW groups.
  • ROC curve analysis: assess how well RDW predicts mortality/readmission and identify a possible cut-off. Report AUC, sensitivity, specificity, and 95% CI.
  • Correlation: Pearson or Spearman correlation if relating RDW to continuous measures such as LVEF, NT-proBNP, or duration of hospital stay.
  • Multivariable linear regression: only if the outcome is continuous, such as length of stay.
Best concise answer for your protocol:
Kaplan-Meier analysis with log-rank test and multivariable Cox proportional-hazards regression will be used to evaluate RDW as an independent prognostic marker for mortality and/or heart-failure hospitalization.
RDW may be entered as a continuous variable (often most statistically efficient, e.g., HR per 1% increase in RDW) and, secondarily, as categories or quartiles for clinical interpretation. Ensure the Cox proportional-hazards assumption is checked.For your study, if the primary outcome is time to death or time to heart-failure readmission, calculate sample size based on the number of outcome events, because the main analysis is Cox proportional-hazards regression.

1. Specify these assumptions first

  1. Primary outcome: all-cause mortality, cardiovascular mortality, or a composite of death/readmission
  2. Follow-up duration: for example, 6 months or 1 year
  3. Expected event rate during follow-up, based on hospital data or published studies
  4. Effect size: the hazard ratio (HR) you wish to detect for high versus low RDW
  5. Significance level: usually two-sided α = 0.05
  6. Power: usually 80% or 90%
  7. Proportion with high RDW: if using a high/low RDW classification
  8. Expected losses to follow-up: commonly 5% to 10%

2. Calculate the required number of events

For RDW categorized as high versus normal/low, use the Schoenfeld formula:
[ D = \frac{(Z_{1-\alpha/2}+Z_{1-\beta})^2} {q(1-q)[\ln(HR)]^2} ]
Where:
  • (D) = required number of events, such as deaths or the composite endpoint
  • (Z_{1-\alpha/2}) = 1.96 for two-sided α = 0.05
  • (Z_{1-\beta}) = 0.84 for 80% power, or 1.28 for 90% power
  • (q) = expected proportion in the high-RDW group
  • (HR) = target hazard ratio for high RDW versus low RDW
This is the standard basis for Cox-regression/log-rank survival-study sample-size planning. Schoenfeld formula overview

3. Convert required events to participants

[ N = \frac{D}{\text{expected event proportion}} ]
Then adjust for loss to follow-up:
[ N_{\text{final}} = \frac{N}{1-\text{anticipated dropout proportion}} ]

Worked example

Assume:
  • Primary outcome: 1-year all-cause mortality
  • Expected HR for high RDW: 1.50
  • High RDW group proportion: 50%
  • α = 0.05, two-sided
  • Power = 80%
  • Expected 1-year event rate: 25%
  • Loss to follow-up: 10%

Required events

[ D = \frac{(1.96+0.84)^2}{0.5(1-0.5)[\ln(1.5)]^2} ]
[ D = \frac{7.84}{0.25 \times 0.1644} = 190.8 ]
So, you need approximately 191 events.

Required participants

[ N = \frac{191}{0.25}=764 ]
Adjustment for 10% loss to follow-up:
[ N_{\text{final}} = \frac{764}{0.90}=849 ]
Required sample size: approximately 850 patients.

Important practical point

If you plan an adjusted Cox model with, for example, RDW plus age, sex, LVEF, NYHA class, hemoglobin, creatinine/eGFR, diabetes, NT-proBNP, and treatment variables, also ensure enough events for the number of parameters. A practical target is at least 10 to 20 events per regression parameter.
For example:
  • 8 variables/parameters in the final model
  • Minimum event target: 80 to 160 events
  • The example calculation requires 191 events, so it is adequate for this model.

Protocol wording

Sample size will be calculated for Cox proportional-hazards regression using the Schoenfeld method. Assuming a two-sided alpha of 0.05, 80% power, hazard ratio of 1.50 for elevated versus normal RDW, equal distribution of participants between RDW groups, an anticipated event rate of 25% during follow-up, and 10% loss to follow-up, approximately 850 participants will be required.
If you provide your expected event rate, intended follow-up period, desired power, and HR from a reference study or pilot data, I can calculate the exact sample size for your protocol.To calculate an exact defensible sample size, I need the assumptions you intend to use.Please send these values and I will calculate the exact number:
  1. Primary outcome: all-cause mortality / HF readmission / death or readmission
  2. Follow-up period: e.g., 6 months or 1 year
  3. Expected event rate during that follow-up: e.g., 20%
  4. Expected hazard ratio for high versus low RDW: e.g., 1.5
  5. Power: 80% or 90%
  6. Significance level: usually 5%, two-sided
  7. Expected loss to follow-up: e.g., 10%
  8. RDW handling: high versus low RDW, quartiles, or continuous RDW
You can reply in this format:
Outcome: death/readmission; follow-up: 1 year; event rate: 30%; HR: 1.5; power: 80%; alpha: 0.05; loss to follow-up: 10%; high RDW proportion: 50%.
Then I will give the required events, final participant sample size, calculation steps, and protocol-ready wording.

Draft the sample-size section for my research protocol

Reading File
Searching the Web

Schoenfeld 1983 sample-size formula proportional hazards regression Cox events formula

Searching PubMed

"heart failure" AND "red cell distribution width"

Finding Sources

Sample Size

The sample size for this prospective observational study will be calculated based on the primary outcome of time to the first adverse prognostic event, defined as all-cause mortality and/or hospital readmission due to heart failure during the follow-up period.
As the primary analysis will use Cox proportional-hazards regression to evaluate the prognostic association between elevated red cell distribution width (RDW) and the outcome, the required number of outcome events will be estimated using the Schoenfeld formula:
[ D = \frac{(Z_{1-\alpha/2}+Z_{1-\beta})^2} {p(1-p)[\ln(HR)]^2} ]
Where:
  • (D) = required number of outcome events
  • (Z_{1-\alpha/2}) = standard normal value for a two-sided alpha level of 0.05 (1.96)
  • (Z_{1-\beta}) = standard normal value corresponding to study power, 0.84 for 80% power
  • (p) = expected proportion of participants with elevated RDW
  • (HR) = anticipated hazard ratio for the primary outcome in participants with elevated RDW compared with those with normal RDW
The overall sample size will then be estimated as:
[ N = \frac{D}{\text{anticipated proportion experiencing the primary outcome}} ]
The calculated sample size will be increased by 10% to account for potential loss to follow-up, incomplete records, or withdrawal from the study.

Example calculation for the protocol

Assuming a two-sided alpha of 0.05, 80% power, an anticipated hazard ratio of 1.50 for the composite outcome among patients with elevated RDW, equal proportions of participants in elevated and normal RDW groups ((p=0.50)), and an expected event rate of 25% during one-year follow-up:
[ D = \frac{(1.96+0.84)^2}{0.50(1-0.50)[\ln(1.50)]^2} ]
[ D = 191 \text{ events} ]
Therefore,
[ N = \frac{191}{0.25}=764 ]
After allowing for 10% loss to follow-up:
[ N_{\text{final}}=\frac{764}{0.90}=849 ]
Thus, a minimum of 850 patients with heart failure will be recruited.
The calculation is based on the Schoenfeld method for survival analysis and Cox proportional-hazards regression. The number should be revised if local hospital data or a selected reference study provides a different expected event rate, hazard ratio, follow-up duration, or proportion with elevated RDW. The event-based approach is appropriate because power in Cox regression depends principally on the number of observed outcome events. Schoenfeld method summary

Add this sentence if you will adjust for confounders

The final multivariable Cox regression model will include clinically relevant confounders such as age, sex, hemoglobin level, renal function, left ventricular ejection fraction, NYHA functional class, diabetes mellitus, and treatment variables. The study will aim to obtain an adequate number of outcome events relative to the number of regression parameters included in the model.
Do not retain “850 patients” unless your planned outcome is the composite death/readmission outcome, your expected event rate is 25%, and you are using the stated HR and power assumptions.

calculate sample size for small study

Reading File
Searching PubMed

"heart failure" AND "red cell distribution width"

Searching the Web

Schoenfeld formula Cox proportional hazards sample size events predictive prognostic study

For a small, single-center observational study, a practical sample size is 100 patients with heart failure.
However, state clearly that it is an exploratory/pilot prognostic study, because a fully powered Cox survival analysis often requires several hundred participants, depending on the event rate and anticipated hazard ratio.

Protocol-ready sample-size section

Sample size

This study will be conducted as a single-center exploratory observational study to evaluate red cell distribution width (RDW) as a prognostic marker in patients with heart failure. Owing to the limited study duration, expected patient availability, and feasibility constraints, a consecutive sample of 100 eligible patients admitted with heart failure during the study period will be recruited.
Assuming an anticipated composite adverse-outcome rate of approximately 25% to 30% during follow-up, recruitment of 100 patients is expected to provide approximately 25 to 30 outcome events. This sample will permit estimation of the association between baseline RDW and adverse outcomes and exploratory survival analysis using Kaplan-Meier curves, log-rank testing, and Cox proportional-hazards regression.
Because the number of expected events is limited, the multivariable Cox regression model will be restricted to RDW and a small number of clinically important covariates, such as age, sex, hemoglobin level/anemia, and renal function. The findings will be interpreted as exploratory and hypothesis-generating.
To account for incomplete records or loss to follow-up, 110 patients may be screened/recruited to obtain data from at least 100 evaluable participants.

Important limitation

With 100 patients, do not include many variables in Cox regression. If you obtain 25 events, limit the final adjusted model to about 2 to 3 prespecified predictors. Otherwise, results can be unstable and overfitted.
For a small study, a defensible primary outcome is a composite endpoint of all-cause death or heart-failure readmission, because it increases the number of events compared with mortality alone. Cox-regression sample size is fundamentally driven by the number of observed events, as described by the Schoenfeld survival-sample method.
This is a shared conversation. Sign in to Orris to start your own chat.